Perinatal Conference Data are integrated with Perinatal Conference Data in
the Perinatal Data Page. Pediatric
Conference Data are integrated with Pediatric Conference Data in
the Pediatric Data Page
Last
Update:
February 11, 2008
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
-
POSTER
Changes in Body Composition
Attributable to Lamivudine, Stavudine, Zidovudine, and Abacavir
in HIV-infected Persons Initiating ART
J Shlay, S Sharma, G Bartsch, et al
PDF Poster
Abstract
-
Low emergence of nevirapine (NVP) and lamivudine (3TC) resistance after
post-partum interruption
of a triple drug regimen for prevention of HIV mother to child transmission
(MTCT)
Pérez H, Vignoles M., Laufer N., Gómez A.
Abstract
-
Formulation development of novel fixed dose combination (FDC) of lamivudine,
nevirapine and
zidovudine for pediatrics
Raghuvanshi R.S, Garg M., Jaiswal A
Abstract
-
A simple, rapid analytical procedure for lamivudine (an antiretroviral agent)
in tablets
Egieyeh S., Builders P., Oqua D.A.N., et al
Abstract
-
POSTER
144-Week Clinical and Immunological Outcome of HIV-1-infected
Subjects Receiving Lamivudine
Monotherapy or Treatment Interruption
A Castagna, A
Danise, L Galli, et al
PDF
Poster
Abstract
-
POSTER
High Prevalence of
Primary Lamivudine and Nelfinavir Resistance in HIV-1-infected
Pregnant
Women in the United States, 1998-2003
R Paredes, I
Cheng, D Kuritzkes, et al
PDF
Poster
Abstract
-
POSTER
Early Virologic
Non-response to Once Daily Combination of Lamivudine, Tenofovir, and
Nevirapine in ART-naive HIV-infected Patients: Preliminary Results of the
DAUFIN Study
D Rey,
MP Schmitt, G Hoizey,
et al
PDF
Poster
Abstract
-
POSTER
Long-term Efficacy of Combination Lamivudine + Tenofovir Therapy in Chronic
HIV/HBV-co-infected Patients
T.E.M.S. de
Vries-Sluijs, R de Man, M Schutten, et al
PDF
Poster
Abstract
8th Int Congress on Drug Therapy in HIV
Infection
|
|
Lamivudine Main Page
2 active drugs in the HAART regimen (CTN 189)